Position in NUVB
as of Jun 30, 2026
· filed Aug 27, 2026
Position Value
$2,470,078
+$993,619 QoQ
Shares Held
434,873
+26.4% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 242 holders
Holding Since
Jun 2023
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $248,190,979 across 122 Biotechnology names. NUVB ranks #23 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
103,755 | $51,538,220 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
196,661 | $15,593,250 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
187,166 | $14,649,482 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
30,558 | $11,357,491 | |
| 5 | TECH |
BIO-TECHNE Corp
|
119,590 | $8,449,033 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,473 | $7,777,414 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,969 | $7,215,387 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
176,956 | $6,584,532 |
All Filings in NUVB
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,470,078 | 434,873 | Shares | Sole | 2026-08-27 | |
| 2026-03-31 | $1,476,459 | 344,163 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,276,762 | 254,103 | Shares | Sole | 2026-03-09 | |
| 2023-06-30 | $29,556 | 16,420 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||